Immune persistence induced by three doses of 60 μg hepatitis B vaccine in non-responders following standard primary vaccination in Chinese adults

References

• Li H, Yan L, Shi Y, Lv D, Shang J, Bai L, Tang H. Hepatitis B virus infection: overview. Adv Exp Med Biol. 2020;1179:1–16. doi:10.1007/978-981-13-9151-4_1.
   PubMed Web of Science ®Google Scholar
• Seto WK, Lo YR, Pawlotsky JM, Yuen MF. Chronic hepatitis B virus infection. Lancet. 2018 Nov 24;392(10161):2313–24. doi:10.1016/S0140-6736(18)31865-8.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global health sector strategy on viral hepatitis 2016–2021. Geneva: World Health Organization; 2016. [accessed 2020 Jul 8]. http://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/.
   Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang S, Wang Q, Shen H, Zhang M, Zhang Y, Yan D, Liu M. Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study. Lancet Infect Dis. 2016 Jan;16(1):80–86. doi:10.1016/S1473-3099(15)00218-2.
   PubMed Web of Science ®Google Scholar
• Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ. 2019 Mar 1;97(3):230–38. doi:10.2471/BLT.18.219469.
   PubMed Web of Science ®Google Scholar
• Wang ZZ, Li MQ, Wang P, Yang ZX, Wei L, Zeng Y, Li YP, Yan L, Liu XE, Zhuang H. Comparative immunogenicity of hepatitis B vaccine with different dosages and schedules in healthy young adults in China. Vaccine. 2016 Feb 17;34(8):1034–39. doi:10.1016/j.vaccine.2016.01.018.
   PubMed Web of Science ®Google Scholar
• Xiao J, Wang F, Wong NK, He J, Zhang R, Sun R, Xu Y, Liu Y, Li W, Koike K, et al. Global liver disease burdens and research trends: analysis from a Chinese perspective. J Hepatol. 2019 Jul;71(1):212–21. doi:10.1016/j.jhep.2019.03.004.
   PubMed Web of Science ®Google Scholar
• Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis. 1999 Feb;179(2):489–92. PMID: 9878036. doi:10.1086/314578.
   PubMed Web of Science ®Google Scholar
• Wang J, He Y, Jin D, Liu J, Zheng J, Yuan N, Bai Y, Yan T, Yang Y, Liu Y, et al. No response to hepatitis B vaccine in infants born to HBsAg(+) mothers is associated to the transplacental transfer of HBsAg. Infect Dis (Lond). 2017 Aug;49(8):576–83. doi:10.1080/23744235.2017.1292541.
   PubMed Web of Science ®Google Scholar
• Yen YH, Chen CH, Wang JH, Lee CM, Changchien CS, Lu SN. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan). Liver Int. 2005 Dec;25(6):1162–68. doi:10.1111/j.1478-3231.2005.01157.x.
   PubMed Web of Science ®Google Scholar
• Joukar F, Mansour-Ghanaei F, Naghipour MR, Asgharnezhad M. Immune responses to single-dose versus double-dose hepatitis B vaccines in healthcare workers not responding to the primary vaccine series: a randomized clinical trial. Hepat Mon. 2016 Feb 27;16(2):e32799. doi:10.5812/hepatmon.32799.
   PubMed Web of Science ®Google Scholar
• Chen X, Gui X, Zhang L, Huang F, Zhong H, Pang Z, Wang S, Tang L, Fu L, Peng Y, et al. Maternal anti-HBVs suppress the immune response of infants to hepatitis B vaccine. J Viral Hepat. 2016 Dec;23(12):955–60. doi:10.1111/jvh.12572.
   PubMed Web of Science ®Google Scholar
• Pan HX, Zeng Y, Song XF, Zhang YJ, Xu K, Liang ZL, Zhu FC. Immune response to hepatitis B vaccine with high antigen content in non-responders after standard primary vaccination in Chinese adults. Vaccine. 2014 Jun 17;32(29):3706–12. doi:10.1016/j.vaccine.2014.02.094.
   PubMed Web of Science ®Google Scholar
• Isolani AP, Sversuti CS, Sell AM, Moliterno RA. Protection against hepatitis B by the Butang recombinant vaccine in newborn children in South Brazil. Mem Inst Oswaldo Cruz. 2006 Aug;101(5):551–53. doi:10.1590/s0074-02762006000500012.
   PubMed Web of Science ®Google Scholar
• Wu W, Lv J, Liu J, Yan B, Feng Y, Xu A, Zhang L. Persistence of immune memory among adults with normal and high antibody response to primary hepatitis B vaccination: results from a five-year follow-up study in China. Hum Vaccin Immunother. 2018;14(10):2485–90. doi:10.1080/21645515.2018.1477911.
   PubMed Web of Science ®Google Scholar
• Pileggi C, Papadopoli R, Bianco A, Pavia M. Hepatitis B vaccine and the need for a booster dose after primary vaccination. Vaccine. 2017 Nov 1;35(46):6302–07. doi:10.1016/j.vaccine.2017.09.076.
   PubMed Web of Science ®Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009 Nov 5;27(47):6550–57. doi:10.1016/j.vaccine.2009.08.048.
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Mariano A, Romanò L, D’Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, et al. Study Group. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet. 2005 Oct 15–21;366(9494):1379–84. doi:10.1016/S0140-6736(05)67568-X
   PubMed Web of Science ®Google Scholar
• Bruce MG, Bruden D, Hurlburt D, Zanis C, Thompson G, Rea L, Toomey M, Townshend-Bulson L, Rudolph K, Bulkow L, et al. Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose. J Infect Dis. 2016 Jul 1;214(1):16–22. doi:10.1093/infdis/jiv748.
   PubMed Web of Science ®Google Scholar
• Poovorawan Y, Chongsrisawat V, Theamboonlers A, Crasta PD, Messier M, Hardt K. Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand. Hum Vaccin Immunother. 2013 Aug;9(8):1679–84. doi:10.4161/hv.24844.
   PubMed Web of Science ®Google Scholar
• Bagheri-Jamebozorgi M, Keshavarz J, Nemati M, Mohammadi-Hossainabad S, Rezayati MT, Nejad-Ghaderi M, Jamalizadeh A, Shokri F, Jafarzadeh A. The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy. Hum Vaccin Immunother. 2014;10(12):3731–36. doi:10.4161/hv.34393.
   PubMed Web of Science ®Google Scholar
• Lin AW, Wong KH. Long-term protection of neonatal hepatitis B vaccination in a 30-year cohort in Hong Kong. J Hepatol. 2013 Dec;59(6):1363–64. doi:10.1016/j.jhep.2013.08.021.
   PubMed Web of Science ®Google Scholar
• Spradling PR, Kamili S, Xing J, Drobeniuc J, Hu DJ, Middleman AB. Response to challenge dose among young adults vaccinated for hepatitis B as infants: importance of detectable residual antibody to hepatitis B surface antigen. Infect Control Hosp Epidemiol. 2015 May;36(5):529–33. doi:10.1017/ice.2015.6.
   PubMed Web of Science ®Google Scholar
• Yao J, Shan H, Chen Y, Jiang ZG, Dai XW, Ren JJ, Xu KJ, Ruan B, Yang SG, Li Q. The one year effects of three doses of hepatitis B vaccine as a booster in anti-HBs-negative children 11-15 years after primary immunization; China, 2009-2011. Hum Vaccin Immunother. 2015;11(5):1114–19. doi:10.4161/21645515.2014.987001.
   PubMed Web of Science ®Google Scholar
• Coppola N, Corvino AR, De Pascalis S, Signoriello G, Di Fiore E, Nienhaus A, Sagnelli E, Lamberti M. The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy. BMC Infect Dis. 2015 Mar 25;15:149. doi:10.1186/s12879-015-0874-3.
   PubMed Web of Science ®Google Scholar
• Zhao YL, Han BH, Zhang XJ, Pan LL, Zhou HS, Gao Z, Hao ZY, Wu ZW, Ma TL, Wang F, et al. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination. BMC Infect Dis. 2019 May 30;19(1):482. doi:10.1186/s12879-019-4134-9.
   PubMedGoogle Scholar
• Zanetti AR, Romanò L, Giambi C, Pavan A, Carnelli V, Baitelli G, Malchiodi G, Valerio E, Barale A, Marchisio MA, et al. study group. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study. Lancet Infect Dis. 2010 Nov;10(11):755–61. doi:10.1016/S1473-3099(10)70195-X.
   PubMed Web of Science ®Google Scholar